ArticleFrontiers in aging neuroscience2024
Differences in cerebral structure among patients with amnestic mild cognitive impairment and patients with Alzheimer's disease.
Article in Frontiers in aging neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications.Inflammopharmacology · 2025Review
- Voxel- and surface-based morphometry in the cortical thickness and cortical and subcortical gray matter volume in patients with mild-to-moderate Alzheimer's disease.Frontiers in aging neuroscience · 2025Article
- Study on brain functional networks and cortical morphological structures in patients with primary insomnia.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brain has been shown to undergo progressive atrophy in patients with Alzheimer's disease (AD); however, more evidence is needed to elucidate how the brain structure changes during the progression to AD. Here, we observed differences in the cerebral structure among patients with amnestic mild cognitive impairment (aMCI) and patients with AD. Methods: A total of 46 participants were selected and divided into AD, aMCI, and healthy control (HC) groups. Structural magnetic resonance imaging (sMRI) was performed on all participants. Voxel-based morphometry (VBM) and surface-based morphometry (SBM) techniques were utilized to analyze sMRI data so as to identify significant differences among the specific brain regions of these three groups. Then, a correlation analysis was performed on the characteristics of the identified brain regions and the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) cognitive assessment scores. Results: The volume of the left precuneus region, which was identified by voxel-based morphometry, and the thickness of both sides of the inferior parietal, which was identified by surface-based morphometry, were shown to be less in AD/aMCI patients, compared to those of the HC. The correlation analysis showed that there were significant differences between the volume of the left precuneus region and the MMSE/MoCA scores, as well as between the thickness of the left and right sides of the inferior parietal region and the MMSE/MoCA scores. Conclusion: The sMRI characteristics of the identified brain regions were considered to be potential predictive diagnostic biomarkers for AD. Systematic review registration: Identifier: ChiCTR2400092593.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.